Andrew Craig Miller - 01 Nov 2022 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Operating Officer
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Nov 2022
Net transactions value: -$3,370,360
Form type: 4
Filing time: 03 Nov 2022, 18:31:31 UTC
Previous filing: 17 Feb 2022
Next filing: 14 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$5,840	+2,000	+3.9%	$2.92^*	53,500	03 Nov 2022	Direct
transaction	KRTX	Common Stock	Sale	$3,376,200	-15,000	-28%	$225.08	38,500	01 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-2,000	-3.4%	$0.000000	56,417	03 Nov 2022	Common Stock	2,000	$2.92	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2022.
F2	This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.